trending Market Intelligence /marketintelligence/en/news-insights/trending/TB8xM04t1uja8kEzh68bRg2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Mylan to recall ulcer drug from US market over cancer-causing impurity

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Mylan to recall ulcer drug from US market over cancer-causing impurity

Mylan NV initiated a voluntary recall of three lots of its Nizatidine capsules in the U.S. market after detecting traces of a potentially cancer-causing substance called N-Nitrosodimethylamine, commonly known as NDMA.

The U.K.-based pharmaceutical company did not receive any reports of adverse events directly related to the recalled batches.

Nizatidine is used to treat ulcers of the stomach and intestines and prevent them from coming back after they have healed. It is also used to treat certain other stomach and throat problems including gastroesophageal reflux disease. The medication works by decreasing the amount of acid the stomach makes.

Previously, Mylan was among the companies that recalled several lots of their generic ranitidine drugs from the U.S. market after finding elevated levels of NDMA in the products.